Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value

• Published in: Nature communications Vol. 6; no. 1; p. 5899
• Main Authors: Stirzaker, Clare, Zotenko, Elena, Song, Jenny Z., Qu, Wenjia, Nair, Shalima S., Locke, Warwick J., Stone, Andrew, Armstong, Nicola J., Robinson, Mark D., Dobrovic, Alexander, Avery-Kiejda, Kelly A., Peters, Kate M., French, Juliet D., Stein, Sandra, Korbie, Darren J., Trau, Matt, Forbes, John F., Scott, Rodney J., Brown, Melissa A., Francis, Glenn D., Clark, Susan J.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 02.02.2015; Nature Publishing Group
• Subjects: 13/106; 631/208/514/1948; 692/699/67/1347; 692/699/67/68/2486; 692/700/1750; Breast cancer; Deoxyribonucleic acid; DNA; DNA Methylation - genetics; DNA Methylation - physiology; Epigenomics; Female; Humanities and Social Sciences; Humans; Methylation; Molecular Sequence Data; multidisciplinary; Prognosis; Science; Science (multidisciplinary); Triple Negative Breast Neoplasms - genetics; Triple Negative Breast Neoplasms - pathology
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/ncomms6899

Epigenetic alterations in the cancer methylome are common in breast cancer and provide novel options for tumour stratification. Here, we perform whole-genome methylation capture sequencing on small amounts of DNA isolated from formalin-fixed, paraffin-embedded tissue from triple-negative breast cancer (TNBC) and matched normal samples. We identify differentially methylated regions (DMRs) enriched with promoters associated with transcription factor binding sites and DNA hypersensitive sites. Importantly, we stratify TNBCs into three distinct methylation clusters associated with better or worse prognosis and identify 17 DMRs that show a strong association with overall survival, including DMRs located in the Wilms tumour 1 ( WT1 ) gene, bi-directional-promoter and antisense WT1-AS. Our data reveal that coordinated hypermethylation can occur in oestrogen receptor-negative disease, and that characterizing the epigenetic framework provides a potential signature to stratify TNBCs. Together, our findings demonstrate the feasibility of profiling the cancer methylome with limited archival tissue to identify regulatory regions associated with cancer. Triple-negative breast cancers (TNBCs) are a heterogeneous group of cancers with varying prognoses. Here, the authors carry out whole-genome methylation capture sequencing from TNBC samples and matched normal samples, and identify differentially methylated regions that define a potentially novel TNBC signature.